In a previous work, with the aim to verify whether Ole might potentiate drug efficiency on BRAF mutant melanoma cells, we decided to use a non-toxic 250 μM dose able to reduce cell proliferation rate without affecting cancer cell viability and apoptosis. The gene discussed is BRAF; the disease is cancer.